Natural and herbal compounds targeting breast cancer, a review based on cancer stem cells
- PMID: 32952942
- PMCID: PMC7478260
- DOI: 10.22038/ijbms.2020.43745.10270
Natural and herbal compounds targeting breast cancer, a review based on cancer stem cells
Abstract
Cancer stem cells (CSCs) are known as the major reason for therapy resistance. Recently, natural herbal compounds are suggested to have a significant role in inhibiting the breast cancer stem cells (BCSCs). The aim of this study was to explore the effective natural herbal compounds against BCSCs.This review article was designed based on the BCSCs, mechanisms of therapy resistance and natural herbal compounds effective to inhibit their activity. Therefore, Science direct, PubMed and Scopus databases were explored and related original articles were investigated from 2010 to 2019. BCSCs use different mechanisms including special membrane transporters, anti-apoptotic, pro-survival, and self-renewal- related signaling pathways. Natural herbal compounds could disturb these mechanisms, therefore may inhibit or eradicate the BCSCs. Studies show that a broad range of plants, either as a food or medicine, contain anti-cancer agents that phenolic components and their different derivatives share a large quantity. Natural herbal compounds play a pivotal role in the eradication of BCSCs, through the inhibition of biological activities and induction of apoptosis. Although it is necessary to conduct more clinical investigation.
Keywords: Breast neoplasm; Neoplasm; Phenolic compounds; Stem cells; Therapy resistance.
Figures
Similar articles
-
Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.Curr Stem Cell Res Ther. 2019;14(8):669-682. doi: 10.2174/1574888X14666190628104721. Curr Stem Cell Res Ther. 2019. PMID: 31808385 Review.
-
Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.Pharmacol Res. 2021 Jan;163:105320. doi: 10.1016/j.phrs.2020.105320. Epub 2020 Dec 1. Pharmacol Res. 2021. PMID: 33271295 Review.
-
Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?Gland Surg. 2017 Feb;6(1):82-88. doi: 10.21037/gs.2016.08.03. Gland Surg. 2017. PMID: 28210556 Free PMC article. Review.
-
Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.Front Oncol. 2020 Apr 30;10:452. doi: 10.3389/fonc.2020.00452. eCollection 2020. Front Oncol. 2020. PMID: 32426267 Free PMC article. Review.
-
WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.Int J Oncol. 2016 Mar;48(3):1175-86. doi: 10.3892/ijo.2016.3337. Epub 2016 Jan 13. Int J Oncol. 2016. PMID: 26781188
Cited by
-
Exploring the Therapeutic Potential for Breast Cancer of Phytochemicals and Secondary Metabolites in Marjoram, Thyme, and Persimmon.Metabolites. 2024 Nov 25;14(12):652. doi: 10.3390/metabo14120652. Metabolites. 2024. PMID: 39728433 Free PMC article. Review.
-
A review of six bioactive compounds from preclinical studies as potential breast cancer inhibitors.Mol Biol Rep. 2025 Feb 5;52(1):203. doi: 10.1007/s11033-025-10300-0. Mol Biol Rep. 2025. PMID: 39907697 Review.
-
Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach.Breast Cancer Res Treat. 2024 Jan;203(1):29-47. doi: 10.1007/s10549-023-07107-7. Epub 2023 Sep 20. Breast Cancer Res Treat. 2024. PMID: 37726449 Free PMC article.
-
Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer.Int J Mol Sci. 2025 Jan 13;26(2):631. doi: 10.3390/ijms26020631. Int J Mol Sci. 2025. PMID: 39859345 Free PMC article. Review.
-
Signaling pathways governing breast cancer stem cells behavior.Stem Cell Res Ther. 2021 Apr 16;12(1):245. doi: 10.1186/s13287-021-02321-w. Stem Cell Res Ther. 2021. PMID: 33863385 Free PMC article. Review.
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–1953. - PubMed
-
- Siegel R MJ, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
-
- Group EBCTC. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 2005;365:1687–1717. - PubMed
-
- Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344. - PubMed
Publication types
LinkOut - more resources
Full Text Sources